Skip to content
Clinical Trials – home

SECALE CEREALE: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
6+
Countries

In short

This article discusses the use of Secale Cereale, commonly known as rye, in clinical trials for allergy treatment. Secale Cereale is one of several grass pollens being studied as part of a mixture for skin prick tests and potential immunotherapy for allergic rhinitis and rhinoconjunctivitis caused by house dust mite allergies. The trials aim to assess the effectiveness and safety of these treatments in managing allergy symptoms and improving patients' quality of life.

At a glance

Study Type
Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study
Main Objective
Assess efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy
Target Condition
Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma Induced by House Dust Mite (HDM) Allergy
Primary Endpoint
Average daily Total Combined Rhinitis Score (TCRS) during the last 8 weeks of treatment
Key Inclusion Criteria
Age 18-65, history of HDM allergic rhinitis, positive skin prick test, elevated specific IgE levels
Key Exclusion Criteria
Severe immune disorders, uncontrolled asthma, recent immunotherapy
Treatment Duration
Approximately 52 weeks
Safety Assessments
Adverse events, local and systemic reactions, asthma-related parameters

What is SECALE CEREALE?

SECALE CEREALE, also known as rye, is a type of grass pollen that is being studied for its potential use in allergy treatments. It is one of several grass pollens included in a mixture being tested for allergen immunotherapy, which is a treatment aimed at reducing allergic reactions in people with certain types of allergies.

Medical Uses

SECALE CEREALE is primarily being investigated for its use in treating allergic rhinitis and rhinoconjunctivitis caused by grass pollen allergies. These conditions involve symptoms such as:

  • Sneezing
  • Runny or stuffy nose
  • Itchy or watery eyes
  • Itchy throat or ears

The treatment containing SECALE CEREALE is being studied specifically for people with moderate to severe symptoms who may also have asthma related to their grass pollen allergy.

How It Works

SECALE CEREALE is used as part of allergen immunotherapy. This type of treatment works by exposing the body to small amounts of the allergen (in this case, grass pollen) over time. The goal is to help the immune system become less sensitive to the allergen, reducing allergic reactions when the person is exposed to grass pollen in their environment.

Administration

In the study mentioned, SECALE CEREALE is being administered as part of a mixture of grass pollens in a solution for skin-prick tests. However, for actual treatment, it would likely be given as a subcutaneous injection (an injection under the skin). The treatment typically involves an initial phase of increasing doses, followed by a maintenance phase with regular injections over an extended period.

Potential Benefits

If proven effective, treatment with SECALE CEREALE as part of a grass pollen mixture could potentially:

  • Reduce the severity of allergy symptoms
  • Decrease the need for allergy medications
  • Improve quality of life for people with grass pollen allergies
  • Potentially prevent the development of asthma in some individuals with allergic rhinitis

Safety and Side Effects

As with any medical treatment, there are potential risks and side effects associated with allergen immunotherapy. These may include:

  • Local reactions at the injection site (redness, swelling, itching)
  • Systemic allergic reactions (in rare cases)
  • Worsening of asthma symptoms (in individuals with asthma)

It's important to note that allergen immunotherapy should only be administered under the supervision of a qualified healthcare professional, typically an allergist.

Ongoing Research

The information about SECALE CEREALE comes from a clinical trial studying its use as part of a grass pollen mixture for allergen immunotherapy. This research aims to assess the effectiveness and safety of this treatment for people with moderate to severe allergic rhinitis or rhinoconjunctivitis caused by grass pollen allergies.

The study is evaluating various aspects of the treatment, including:

  • Its effect on allergy symptoms
  • The need for allergy medications
  • Changes in quality of life
  • Safety and tolerability of the treatment
  • Its impact on asthma in participants who have both allergies and asthma

It's important to remember that while this research is promising, SECALE CEREALE as part of this specific treatment is still under investigation. More studies may be needed before it becomes widely available as a treatment option.

Questions people often ask

Conditions where Secale Cereale is being studied

Each condition opens its own overview and trial list

Trials with Secale Cereale

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.